Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patients.

Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patients.

BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antiretroviral treatment are related to assay variation and/or increased sensitivity of new commercial assays. The 50-copy cut-off for virologic failure is, therefore, under debate. METHODS: Treated patient...

Full description

Bibliographic Details
Main Authors: Laura Marije Hofstra, Tania Mudrikova, Arjen J Stam, Sigrid Otto, Kiki Tesselaar, Monique Nijhuis, Annemarie M J Wensing
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4212971?pdf=render

Internet

http://europepmc.org/articles/PMC4212971?pdf=render

Similar Items